Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jul 20;23(1):243.
doi: 10.1186/s12871-023-02210-0.

Intravenous lidocaine improves postoperative cognition in patients undergoing laparoscopic colorectal surgery: a randomized, double-blind, controlled study

Xian-Xue Wang  1   2 , Jing Dai  2 , Qi Wang  2 , Hui-Wei Deng  2 , Yun Liu  2 , Gui-Fan He  2   3 , Hua-Jing Guo  2 , Ya-Lan Li  4
Affiliations
Randomized Controlled Trial

Intravenous lidocaine improves postoperative cognition in patients undergoing laparoscopic colorectal surgery: a randomized, double-blind, controlled study

Xian-Xue Wang et al. BMC Anesthesiol. .

Retraction in

Abstract

Background: The risk of postoperative cognitive dysfunction(POCD) in laparoscopic surgery should not be overlooked. Intravenous lidocaine can reduce perioperative inflammatory response in patients undergoing laparoscopic surgery, while the effect of intraoperative intravenous lidocaine on postoperative cognitive function in patients undergoing laparoscopic colorectal cancer surgery has not been well studied. We investigated whether intraoperative lidocaine improves postoperative cognitive function after laparoscopic radical resection for colorectal cancer.

Methods: We conducted a prospective, randomized double blinded controlled trial to investigate the effect of intravenous lidocaine on rapid postoperative recovery in patients undergoing laparoscopic radical resection of colorectal cancer. The patients were randomly assigned to receive either intravenous lidocaine or saline. The primary outcome was cognitive dysfunction defined by a decrease from pre- to postoperative ≥ 2 of the Mini-Mental State Examination (MMSE) score, at the 3rd and the 7th postoperative days. Secondary outcomes were the MMSE raw score and parameters of the patients' postoperative recovery such as agitation and length of stay in the post-anaesthesia care unit (PACU), length of hospital stay, markers of inflammation (white blood cell count and CRP), and incidence of complications.

Results: Seventy-three patients in the lidocaine group and 77 patients in the control group completed the trial. The rate of cognitive dysfunction was lower in the lidocaine group than that in the control group, both at the 3rd (18.57% vs. 63.64% for each group respectively; RR = 0.26, 95%CI = 0.19-0.32; p < 0.0001) and at the 7th postoperative day (12.33% vs. 53.25% for each group respectively; RR = 0.28, 95%CI = 0.22-0.35; P < 0.001). The postoperative MMSE scores were also higher in the lidocaine group than in the control group both at the 3rd (median 25 vs. 24 respectively) and at the 7th postoperative day (26 vs. 24 respectively). Also, patients in the lidocaine group displayed a lower white blood cell count than the control group at the 1st postoperative day (8.5 ± 2.7 vs. 10.4 ± 3.3; p < 0. 001). No differences were evidenced for the other secondary outcomes.

Conclusions: Intraoperative intravenous lidocaine can significantly improve postoperative cognitive function in patients undergoing laparoscopic radical resection of colorectal cancer.

Trial registration: Chinese Clinical Trial Registry (16/1/2022, registration number: ChiCTR2200055683).

Keywords: Laparoscopic colorectal surgery; Lidocaine; Postoperative cognitive dysfunction; Randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study flow diagram
Fig. 2
Fig. 2
Comparison of the perioperative MMSE scores between the two groups
See this image and copyright information in PMC

References

    1. Hermanns H, Wollmanm MW, Stevens MF, et al. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review[J] Br J Anaesth. 2019;123(3):335–49. doi: 10.1016/j.bja.2019.06.014. - DOI - PubMed
    1. Greenwood E, Nimmo S, Paterson H, et al. Intravenous lidocaine infusion as a component of multimodal analgesia for colorectal surgery-measurement of plasma levels[J] Perioper Med(Lond) 2019;8:1. doi: 10.1186/s13741-019-0112-4. - DOI - PMC - PubMed
    1. Liu HQ, Li J, Liu XL, et al. Folic acid and RAAS blockers in ischemia/reperfusion-induced hepatic injury: a current mechanistic concept for understanding the incidence, significance & outcome[J] Chem Biol Interact. 2020;327:109187. doi: 10.1016/j.cbi.2020.109187. - DOI - PubMed
    1. Lee IW, Schraag S. The Use of Intravenous Lidocaine in Perioperative Medicine: Anaesthetic, Analgesic and Immune-Modulatory aspects. J Clin Med. 2022;11(12):3543. doi: 10.3390/jcm11123543. - DOI - PMC - PubMed
    1. Crouch CE, Wilkey BJ, Hendrickse A, et al. Lidocaine intraoperative infusion pharmacokinetics during partial hepatectomy for living liver donation. Anesthesiology. 2023;138(1):71–81. doi: 10.1097/ALN.0000000000004422. - DOI - PubMed

Publication types